Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 61 results for "cadila healthcare"

Cadila Healthcare Q3 PAT seen up 9.5% to Rs 369.6 cr: KR Choksey
Money Control

Cadila Healthcare Q3 PAT seen up 9.5% to Rs 369.6 cr: KR Choksey

Net Sales are expected to increase by 7.5 percent Q-o-Q (up 7.3 percent Y-o-Y) to Rs 2512.6 crore, according to KR Choksey. Money Control, 1 week ago
Cadila Healthcare Q3 net dips 34.6% Business Line, 1 month ago

60 images for cadila healthcare

Money Control, 1 week ago
Business Standard, 3 weeks ago
Money Control, 1 week ago
Money Control, 5 days ago
Money Control, 1 month ago, 1 month ago, 1 month ago, 1 month ago
Sify, 3 weeks ago
Money Today, 1 month ago
Money Control

Zydus Cadila gets USFDA nod to market muscle relaxant in US

Drug firm Zydus Cadila has received approval from the USFDA to market tizanidine hydrochloride capsules, a muscle relaxant, in the American market. "The company has received final approval from the US Food and Drug Administration (USFDA) to market tizanidine ...
 Business Standard3 weeks ago Zydus Cadila receives final approval from USFDA for Tizanidine Hydrochloride capsules  Money Control3 weeks ago Zydus Cadila receives USFDA nod to market fluconazole tablets  Business Standard1 month ago Aim to develop and market molecules in India first: Zydus Cadila  Money Control1 month ago

Cadila Healthcare gets 3 USFDA observations for Baddi plant

Drug firm Cadila Healthcare today said the US health regulator has given three observations after completing inspection of the its facility at Baddi in Himachal Pradesh.
 DNA3 weeks ago US regulator observations at Baddi unit may not effect Cadila  Business Standard3 weeks ago Meeting manufacturing norms, says Cadila Healthcare after USFDA inspection  DNA1 month ago
Business Standard

Cadila Healthcare falls 7% on US FDA observations at Baddi plant

The US Food and Drug Administration (FDA) gave three observations under Form 483 for its formulations manufacturing facility at Baddi. These were related to pre-approval inspections for a specific product filed.
 Money Control3 weeks ago Cadila Healthcare's Baddi unit receives 3 observations under Form 483  Business Standard3 weeks ago

Cadila Healthcare gets Form 483 from USFDA; Stock recovers after sharp setback

Cadila Healthcare Limited shares tanked to Rs 407.25, losing about 7% in the process, after the company said USFDA issued three observations after inspecting the company's facility at Baddi. The stock recovered swiftly from that level and is currently trading ...
 Sify3 weeks ago USFDA inspects Cadila Healthcare's Moraiya facility  Money Control1 month ago

Cadila shares extend gains; surge over 7 pc

Shares of Cadila Healthcare surged another 7 per cent today after the company said the US health regulator has inspected the firm's Moraiya plant and found it in compliance with manufacturing norms. The stock jumped 7.11 per cent to Rs 460 -- its 52-week high ...
 Business Standard1 month ago BUZZ-India's Cadila Healthcare surges; U.S. FDA unit inspection ends successfully  Sify1 month ago
Money Control

Cadila inks pact with Supernus Pharma to settle patent issue

Cadila Healthcare today said that it has finalised a pact with Supernus Pharmaceuticals to settle patent litigation regarding Trokendi XR extended-release capsules, used for treatment of seizures. Cadila Healthcare, along with subsidiary Zydus Pharmaceuticals ...
 Business Standard3 weeks ago
Money Control

Cadila settles patent litigation related to Livalo tablets

Drug firm Cadila Healthcare has settled all outstanding patent litigation related to Livalo tablets with Kowa Company, Kowa Pharmaceuticals America Inc and Nissan Chemical Industries Ltd. The company and its subsidiary, Zydus Pharmaceuticals (USA) Inc, have ...
 Business Line2 months ago Cadila Healthcare gains after announcing settlement on Livalo tablets  Business Standard2 months ago Cadila's subsidiary settles its patent litigation  India Infoline2 months ago

S&P BSE 500 index hits record high

HDFC Bank, IndusInd Bank, Cadila Healthcare, Biocon, TVS Motor, Alkem Lab, Escorts, SJVN and CESC hit record highs.
 Business Standard1 month ago

Cadila Healthcare inches closer to net profit upgrades

The company is on course to sort out various issues raised by the FDA
 Business Standard1 month ago Cadila Healthcare net profit declines 34.6% in Q3  Prokerala1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less